This site is intended for Healthcare Professionals only.

GPhC commits to playing its part in addressing climate change

Date:

Share post:

The General Pharmaceutical Council (GPhC) has committed to playing its part in addressing climate change by undertaking work to establish a carbon footprint baseline to improve its environmental performance.

In a statement on Monday (July 18) the pharmacy regulator laid out what it called its vision “to have safe and effective pharmacy care at the heart of healthier communities”.

Stating that climate change creates health risks and exacerbates health inequalities, GPHC said: “We believe we all have a role to play in contributing to addressing climate change.”

It announced that it has just joined “a newly formed cross-regulatory group” formed to address issues such as “environmental sustainability”.

“At the GPhC we have brought together colleagues from across the organization to consider the environmental impact we have as an employer and as a regulator,” it declared.

“This is just the beginning of our journey. As our work progresses we want to work with all our stakeholders to understand their priorities and consider how we can all work together to make a contribution to addressing climate change,” the statement added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...